Mercanto HoldingsTGSHF 34 Current Ratio is 1.41 as of Apr. 2026, which is 11% below its 10-year median of 1.59. GuruFocus rates TGSHF with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 995 Drug Manufacturers companies, Mercanto Holdings ranks worse than 74.87% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Mercanto Holdings's current ratio for the quarter that ended in Apr. 2026 was 1.41.
Mercanto Holdings has a current ratio of 1.41. It generally indicates good short-term financial strength.
The historical rank and industry rank for Mercanto Holdings's Current Ratio or its related term are showing as below:
TGSHF'
s Current Ratio Range Over the Past 10 Years
Min: 1.09 Med: 1.59 Max: 12.16
Current: 1.41
During the past 5 years, Mercanto Holdings's highest Current Ratio was 12.16. The lowest was 1.09. And the median was 1.59.
TGSHF's Current Ratio is ranked worse than 74.87% of 995
companies
in the Drug Manufacturers industry
Industry Median: 2
vs TGSHF: 1.41
Mercanto Holdings (OTCPK:TGSHF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Mercanto Holdings Current Ratio Related Terms
Mercanto Holdings Current Ratio Historical Data
* Premium members only.
The historical data trend for Mercanto Holdings's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Mercanto Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mercanto Holdings Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mercanto Holdings's Current Ratio distribution charts can be found below:
* The bar in red indicates where Mercanto Holdings's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mercanto Holdings (TGSHF) has a Current Ratio of 1.41 as of Apr. 2026. This is 11% below median its historical median of 1.59. Over the past decade, Mercanto Holdings' Current Ratio has ranged from 1.09 to 12.16. According to the industry distribution chart, Mercanto Holdings ranks #745 out of 995 companies in the Drug Manufacturers industry, placing it in the top 74.9%.
Is Mercanto Holdings' Current Ratio too high?
Mercanto Holdings' current Current Ratio of 1.41 is 11% below median its 10-year median of 1.59. Over the past 10 years, this metric has ranged from a low of 1.09 to a high of 12.16. The Drug Manufacturers industry median Current Ratio is 2.00. Mercanto Holdings' value of 1.41 is 29.5% below this industry median. Based on the distribution chart, Mercanto Holdings ranks #745 out of 995 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Mercanto Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Mercanto Holdings' Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Mercanto Holdings ranks #745 out of 995 companies for Current Ratio. This places Mercanto Holdings in the lower half of its industry. The industry median Current Ratio is 2.00. Mercanto Holdings' value of 1.41 is 29.5% below this benchmark. Historically, Mercanto Holdings' own Current Ratio has ranged from 1.09 to 12.16 over the past decade. While the company's 10-year median is 1.59 vs. the industry median of 2.00, Mercanto Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 995 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mercanto Holdings's current Current Ratio of 1.41 is 29.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mercanto Holdings's current Current Ratio is 1.41, which is 11% below median its own 10-year median of 1.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercanto Holdings stock overvalued right now?
Mercanto Holdings (TGSHF) has a current Current Ratio of 1.41. The current Current Ratio is 1.41, which is 11% below median its 10-year median of 1.59 and 29.5% below the Drug Manufacturers industry median of 2.00. Mercanto Holdings' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Mercanto Holdings (TGSHF), the current Current Ratio is 1.41 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mercanto Holdings Inc operates a portfolio of brands that include traditional cannabis and beverage products. The company exists to promote the use of mushrooms through its brands; The company offers quality products that promote health, recreation, and well-being. The portfolio of the company includes different cannabis products, probiotic, functional mushroom beverages, and others.
34GF Score
Get the complete analysis for TGSHF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TGSHF has been successfully added to your 
